According to Celltrion 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.9723. At the end of 2022 the company had a P/E ratio of 42.1.
Year | P/E ratio | Change |
---|---|---|
2022 | 42.1 | -11.55% |
2021 | 47.6 | -49.67% |
2020 | 94.5 | 17.79% |
2019 | 80.3 | -27.67% |
2018 | 111 | 47.95% |
2017 | 75.0 | -9% |
2016 | 82.4 | 25.66% |
2015 | 65.6 | 78.62% |
2014 | 36.7 | -3.29% |
2013 | 38.0 | 126.06% |
2012 | 16.8 | -28.83% |
2011 | 23.6 | -31.39% |
2010 | 34.4 | 31.39% |
2009 | 26.2 | -123.93% |
2008 | -109 | -1596.8% |
2007 | 7.31 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.